FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention relates to novel inclusion complexes of derivatives of 1,2,5-oxadiazole-2-oxide of the general formula (I) where R1 = R2 is CN or in common with adjacent carbon atoms form annelated 3,6-bis-(lower alkyl)-pyridazine-1,2-dioxide cycle with polycyclic derivatives of glucopyranose of the general formula (II) where if n = 1 then R3 means a fragment of 11-oxo-18β, 20β-olean-12-ene-29-oic acid of the formula (III) R4 is H; R5 is β-D-glucopyranosyl; R6 = R7 is H; R8 means C(O)OH; and if n = 7 then R3 is H; R4 and R7 are direct bonds; R5 and R6 mean H or (CH2CH(CH3)O)mH where m = 1-14; R8 means -CH2OH or CH2O(CH2CH(CH3)O)mH where m = 1-14. New compounds produce nitrogen oxide and activate the soluble form of guanylate cyclase and relate to spasmolytic, vasodilating and hypotensive agents of rapid effect and they are inhibitors of platelet aggregation. Invention relates to a method of their synthesis and pharmaceutical compositions based on thereof. The proposed compounds are synthesized by the method involving interaction of the parent derivative of 1,2,5-oxadiazole-2-oxide of the above given formula (I) where and R2 have the indicated values with the corresponding polycyclic derivative of glucopyranose of the above given general formula (II) where R3-R8 have the indicated values. Synthesis is carried out in an aqueous-organic medium (for example, in an aqueous solution of dioxane, lower alkanol, in part ethanol, or a mixture of organic solvents) at increased temperature 30-60 C followed by isolation of the end product by evaporation under decreased pressure, its washing out with low-polar inert organic solvent (diethyl ether or its mixture with hexane) and drying under decreased pressure. Novel inclusion complexes are effective donors of NO and produce its redox-form (nitroxyl) also, form nitrosothiols and activate guanylate cyclase soluble form and show also spasmolytic, vasodialting and rapid hypotensive effect. The described compounds show the expressed anti-aggregative properties also. EFFECT: valuable medicinal properties. 16 cl, 4 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
1,2,5-OXADIAZOLO[3,4-D]PYRIDAZINE-5,6-DIOXIDE DERIVATIVES AS ACTIVATORS OF SOLUBLE FORM OF GUANYLATE-CYCLASE AND AGENTS ACTIVE IN TREATMENT OF CENTRAL NERVOUS SYSTEM, AND COMPOSITIONS BASED ON THESE COMPOUNDS | 1997 |
|
RU2165256C2 |
DONOR OF NITROGEN OXIDE ACTIVATING SOLUBLE FORM OF GUANYLATE CYCLASE, INHIBITING PLATELET AGGREGATION AND EXHIBITING SPASMOLYTIC AND VASODILATING EFFECT | 2001 |
|
RU2208438C1 |
DERIVATIVES OF 1,4,2,5-DIOXADIAZINE | 2001 |
|
RU2212409C1 |
INHIBITOR OF NO-DEPENDENT ACTIVATION OF SOLUBLE FORM OF GUANYLATE CYCLASE | 2001 |
|
RU2189392C1 |
SPECIFIC REGULATOR OF ACTIVITY OF NUCLEOTIDE-DEPENDENT ENZYMES | 1997 |
|
RU2130490C1 |
DONOR OF NITROGEN OXIDE AND ACTIVATOR OF SOLUBLE FORM OF GUANYLATE CYCLASE | 1998 |
|
RU2139932C1 |
INHIBITOR OF NO-DEPENDENT ACTIVATION OF GUANYLATE CYCLASE SOLUBLE FORM | 2001 |
|
RU2188865C1 |
DONOR OF NITROGEN OXIDE AND ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2123046C1 |
ANTIHYPOXIC COMPLEX | 1997 |
|
RU2137478C1 |
INHIBITOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1999 |
|
RU2151799C1 |
Authors
Dates
2002-08-10—Published
2001-01-16—Filed